Supreme Court Clarifies When Commercial or Financial Information Is Confidential Under the Freedom of Information Act
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
FOOD MARKETING INSTITUTE V. ARGUS LEADER MEDIA.
Before the Supreme Court with J. Gorsuch delivering the majority opinion.
Summary: Commercial or financial information is confidential under the Freedom of Information Act (FOIA) when it is (1) both customarily and actually treated as private by its owner and (2) provided to the government under an assurance of privacy.
Argus Leader Media filed a FOIA request with the Department of Agriculture (USDA) seeking information submitted to the USDA from stores in national food-stamp program. The USDA declined under FOIA’s Exemption 4 that shields “trade secrets and commercial or financial information obtained from a person and privileged or confidential” from disclosure. Argus Leader sued to compel the USDA information. The district court, employing Eighth Circuit precedent, found that the stores’ data was not “confidential” because disclosure would not cause substantial competitive harm. When the USDA declined to appeal, the Food Marketing Institute intervened and appealed to the Eighth Circuit, which affirmed the district court’s decision. The Supreme Court granted the Institute a stay of the Eighth Circuit’s mandate and later granted certiorari.
In a 6-3 decision, the Court rejected the Eighth Circuit’s “competitive harm” test for confidential commercial or financial information. The Court observed that this test originated from a highly-criticized 1974 D.C. Circuit decision that relied on witness statements from a congressional hearing on a different, unpassed bill. The Court held that “where commercial or financial information is both customarily and actually treated as private by its owner and provided to the government under an assurance of privacy, the information is ‘confidential’ within Exemption 4’s meaning.”
Editor: Paul Stewart
Written by: James Smith and Nicole R. Townes
More insights
Skinny Labels at the Supreme Court: Carving Out Room for Generics to Breathe
Written by : Ari Feinstein and Zoe E. Vikstrom HIKMA PHARMACEUTICALS USA INC. et al. v. AMARIN PHARMA, INC., et al. Jackson, J., delivered the opinion for a unanimous Court. Certiorari to the United States Court of Appeals for the Federal Circuit. Summary:…

U.S. Supreme Court Declines to Hear Patent Appeal Against Apple, Google, and LG
In a closely watched dispute that sits at the intersection of patent validity, administrative review, and high-stakes smartphone litigation, the U.S. Supreme Court on November 17, 2025, declined to hear an appeal brought by Gesture Technology Partners…
3-2-1 Blast Off: US Space Force Trademark Dispute Aims for the Supreme Court
Written by : Ian W. Gillies The trademark attorney Thomas D. Foster has found himself in ongoing legal star wars to register US SPACE FORCE as his personal trademark covering coins, jewelry, watches, license plate holders, toys, and other everyday goods.…